GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elos Medtech AB (STU:EI9) » Definitions » Cyclically Adjusted Revenue per Share

Elos Medtech AB (STU:EI9) Cyclically Adjusted Revenue per Share : €5.44 (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Elos Medtech AB Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Elos Medtech AB's adjusted revenue per share for the three months ended in Sep. 2023 was €2.634. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €5.44 for the trailing ten years ended in Sep. 2023.

During the past 12 months, Elos Medtech AB's average Cyclically Adjusted Revenue Growth Rate was 15.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Elos Medtech AB was 4.90% per year. The lowest was 3.80% per year. And the median was 4.35% per year.

As of today (2024-06-10), Elos Medtech AB's current stock price is €17.70. Elos Medtech AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 was €5.44. Elos Medtech AB's Cyclically Adjusted PS Ratio of today is 3.25.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Elos Medtech AB was 4.37. The lowest was 1.60. And the median was 3.64.


Elos Medtech AB Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Elos Medtech AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elos Medtech AB Cyclically Adjusted Revenue per Share Chart

Elos Medtech AB Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 7.67 6.77

Elos Medtech AB Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.99 5.95 5.35 5.15 5.44

Competitive Comparison of Elos Medtech AB's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Elos Medtech AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elos Medtech AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elos Medtech AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Elos Medtech AB's Cyclically Adjusted PS Ratio falls into.



Elos Medtech AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Elos Medtech AB's adjusted Revenue per Share data for the three months ended in Sep. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=2.634/130.2235*130.2235
=2.634

Current CPI (Sep. 2023) = 130.2235.

Elos Medtech AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201309 1.433 100.544 1.856
201312 1.622 100.541 2.101
201403 1.500 99.788 1.958
201406 1.676 100.432 2.173
201409 1.389 100.161 1.806
201412 1.696 100.225 2.204
201503 1.714 99.950 2.233
201506 2.254 99.995 2.935
201509 1.970 100.228 2.560
201512 2.208 100.276 2.867
201603 2.272 100.751 2.937
201606 2.442 101.019 3.148
201609 1.989 101.138 2.561
201612 2.063 102.022 2.633
201703 2.442 102.022 3.117
201706 2.637 102.752 3.342
201709 2.294 103.279 2.892
201712 2.253 103.793 2.827
201803 2.486 103.962 3.114
201806 2.001 104.875 2.485
201809 1.831 105.679 2.256
201812 2.037 105.912 2.505
201903 2.233 105.886 2.746
201906 2.146 106.742 2.618
201909 1.821 107.214 2.212
201912 1.872 107.766 2.262
202003 1.811 106.563 2.213
202006 1.398 107.498 1.694
202009 1.756 107.635 2.125
202012 1.886 108.296 2.268
202103 2.086 108.360 2.507
202106 2.218 108.928 2.652
202109 2.280 110.338 2.691
202112 2.223 112.486 2.574
202203 2.288 114.825 2.595
202206 2.723 118.384 2.995
202209 2.652 122.296 2.824
202303 2.953 127.042 3.027
202306 2.854 129.407 2.872
202309 2.634 130.224 2.634

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Elos Medtech AB  (STU:EI9) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Elos Medtech AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=17.70/5.44
=3.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Elos Medtech AB was 4.37. The lowest was 1.60. And the median was 3.64.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Elos Medtech AB Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Elos Medtech AB's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Elos Medtech AB (STU:EI9) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Torsgatan 5B, Gothenburg, SWE, 411 04
Elos Medtech AB operates in the medical technology business. It develops and produces medical technology products and components. The company operates through three business segments including Dental, Orthopedics, and Life science. Some of its products include Implants, Screws, Plates, Prosthetics, and Drills.

Elos Medtech AB (STU:EI9) Headlines

No Headlines